Search for a command to run...
Zenotech Laboratories Ltd. is significantly underperforming its peers in terms of growth, profitability, and valuation metrics. While other companies in the sector show profitable operations and attractive growth rates, Zenotech struggles with negative growth and returns, making it a less favorable investment option.
Stocks | CMP | Market Cap | P/E | ROCE (%) | Debt/Equity |
---|---|---|---|---|---|
Zenotech Laboratories Ltd. | ₹56.39 | ₹344.15Cr | 65.43 | -9.32% | 0.11 |
SUNPHARMA | ₹1,563.35 | ₹3,75,099.26Cr | 87.59 | 17.60% | 0.04 |
DIVISLAB | ₹6,091.05 | ₹1,61,698.50Cr | 73.20 | 16.46% | - |
CIPLA | ₹1,587.60 | ₹1,28,217.27Cr | 23.73 | 22.77% | 0.01 |
TORNTPHARM | ₹3,581.55 | ₹1,21,215.77Cr | 61.53 | 24.28% | 0.57 |
DRREDDY | ₹1,280.30 | ₹1,06,835.27Cr | 15.50 | 26.86% | 0.07 |
MANKIND | ₹2,518.95 | ₹1,03,926.59Cr | 55.18 | 28.38% | 0.02 |